---
figid: PMC4019268__jdi-4-152-g1
figtitle: Proposed mechanism underlying disrupted brain insulin signaling in Alzheimer's
  disease (AD)
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC4019268
filename: jdi-4-152-g1.jpg
figlink: /pmc/articles/PMC4019268/figure/jdi12031-fig-0001/
number: F1
caption: Proposed mechanism underlying disrupted brain insulin signaling in Alzheimer's
  disease (AD). (a) Oligomers of amyloid‐β peptide (AβOs) stimulate tumor necrosis
  factor (TNF)‐α signaling, which activates the Jun N‐terminal kinase (JNK) pathway
  and, possibly, ribonucleic acid‐dependent protein kinase (PKR) and IκB kinase (IKK)
  pathways. Activation of these stress‐sensitive kinases results in serine phosphorylation
  of insulin receptor substrate‐1 (IRS‐1) and blocks downstream insulin signaling.
  (b) Stimulation of insulin and glucagon‐like peptide 1 receptors (GLP1R) blocks
  AβOs‐induced defects in insulin signaling. In both panels, red arrows indicate inhibitory
  pathways and green arrows indicate stimulatory pathways of insulin signaling. Reproduced
  from Bomfim et al. with permission from the American Society for Clinical Investigation.
  AKT, protein kinase B (AKT/PKB); Ex‐4, exendin‐4; I, insulin; IR, insulin receptor;
  P, phosphate; PI3K, phosphoinositide 3‐kinase; pSER, serine phosphate; pTyr465,
  tyrosine465 phosphate; TNFR, TNF receptors.
papertitle: New therapeutic strategy for Alzheimer's disease using antidiabetes agents.
reftext: Koichi Yokono. J Diabetes Investig. 2013 Mar 18;4(2):152-153.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9572404
figid_alias: PMC4019268__F1
figtype: Figure
redirect_from: /figures/PMC4019268__F1
ndex: c3fd8edb-dee6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4019268__jdi-4-152-g1.html
  '@type': Dataset
  description: Proposed mechanism underlying disrupted brain insulin signaling in
    Alzheimer's disease (AD). (a) Oligomers of amyloid‐β peptide (AβOs) stimulate
    tumor necrosis factor (TNF)‐α signaling, which activates the Jun N‐terminal kinase
    (JNK) pathway and, possibly, ribonucleic acid‐dependent protein kinase (PKR) and
    IκB kinase (IKK) pathways. Activation of these stress‐sensitive kinases results
    in serine phosphorylation of insulin receptor substrate‐1 (IRS‐1) and blocks downstream
    insulin signaling. (b) Stimulation of insulin and glucagon‐like peptide 1 receptors
    (GLP1R) blocks AβOs‐induced defects in insulin signaling. In both panels, red
    arrows indicate inhibitory pathways and green arrows indicate stimulatory pathways
    of insulin signaling. Reproduced from Bomfim et al. with permission from the American
    Society for Clinical Investigation. AKT, protein kinase B (AKT/PKB); Ex‐4, exendin‐4;
    I, insulin; IR, insulin receptor; P, phosphate; PI3K, phosphoinositide 3‐kinase;
    pSER, serine phosphate; pTyr465, tyrosine465 phosphate; TNFR, TNF receptors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ABO
  - TNF
  - TNFRSF1A
  - EIF2AK2
  - MAPK8
  - MAPK9
  - MAPK10
  - IKBKB
  - IRS1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - Abo
  - Tnf
  - Tnfrsf1a
  - Eif2ak2
  - Mapk8
  - Ikbkb
  - Irs1
  - Pik3r1
  - Akt1
  - abo
  - ABO-2R
  - ABO-X
  - ABO-YL
  - ABO-YS
  - ha
  - egr
  - wgn
  - bsk
  - IKKbeta
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
---
